BioCardia, Inc. Total Liabilities
BioCardia, Inc. (BCDA) had Total Liabilities of $2.06 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Liabilities
us-gaap:Liabilities · last filed 2026-08-12
- 2026-06-30: Liabilities $2.06M.
- 2026-03-31: Liabilities $2.78M.
- 2025-12-31: Liabilities $2.52M.
- 2025-09-30: Liabilities $3.52M.
| Period end | Liabilities | Liabilities as first filed |
|---|---|---|
| 2026-06-30 | $2.06M 10-Q · filed 2026-08-12 | |
| 2026-03-31 | $2.78M 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $2.52M 10-Q · filed 2026-08-12 | |
| 2025-09-30 | $3.52M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $3.98M 10-Q/A · filed 2025-10-29 | |
| 2025-03-31 | $3.69M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $2.89M 10-K · filed 2026-03-24 | |
| 2024-09-30 | $3.51M 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $4.85M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $4.95M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $4.59M 10-K · filed 2025-03-26 | |
| 2023-09-30 | $4.41M 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $4.75M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $5.23M 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $4.90M 10-K · filed 2024-03-27 | |
| 2022-09-30 | $5.08M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $4.53M 10-Q · filed 2022-08-10 | |
| 2022-03-31 | $5.47M 10-Q · filed 2022-05-11 | |
| 2021-12-31 | $5.34M 10-K · filed 2023-03-29 | |
| 2021-09-30 | $3.92M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $4.54M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $4.75M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $4.25M 10-K · filed 2022-03-29 | |
| 2020-09-30 | $5.39M 10-Q · filed 2020-11-10 | |
| 2020-06-30 | $5.84M 10-Q · filed 2020-08-13 | |
| 2020-03-31 | $5.67M 10-Q · filed 2020-05-15 | |
| 2019-12-31 | $5.31M 10-K · filed 2021-03-30 | |
| 2019-09-30 | $5.49M 10-Q · filed 2019-11-19 | |
| 2019-06-30 | $4.95M 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $4.34M 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $2.63M 10-K · filed 2020-04-09 | |
| 2018-09-30 | $2.61M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $1.90M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $2.20M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $2.41M 10-K · filed 2019-04-02 | |
| 2017-09-30 | $2.08M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $1.68M 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $1.43M 10-Q · filed 2017-05-11 | |
| 2016-12-31 | $1.50M 10-K · filed 2018-03-16 | |
| 2016-09-30 | $330.00K 10-Q · filed 2016-10-17 | |
| 2016-06-30 | $0.00 10-Q · filed 2016-08-02 | |
| 2016-03-31 | $0.00 10-Q · filed 2016-05-03 | |
| 2015-12-31 | $8.30M 10-K · filed 2017-03-30 | $10.00K 10-K · filed 2016-03-25 |
| 2015-09-30 | $0.00 10-Q · filed 2015-10-29 | |
| 2015-06-30 | $4.00K 10-Q · filed 2015-08-12 | |
| 2015-03-31 | $0.00 10-Q · filed 2015-05-12 | |
| 2014-12-31 | $10.00K 10-K · filed 2016-03-25 | $1.00K 10-K · filed 2015-03-24 |
| 2014-09-30 | $5.00K 10-Q · filed 2014-11-06 | |
| 2014-06-30 | $1.00K 10-Q · filed 2014-08-06 | |
| 2014-03-31 | $1.00K 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $1.00K 10-K · filed 2015-03-24 | $18.00K 10-K · filed 2014-03-24 |
| 2013-09-30 | $3.00K 10-Q · filed 2013-11-01 | |
| 2013-06-30 | $3.00K 10-Q · filed 2013-07-26 | |
| 2013-03-31 | $10.00K 10-Q · filed 2013-05-10 | |
| 2012-12-31 | $12.00K 10-K · filed 2014-03-24 | |
| 2012-09-30 | $141.00K 10-Q · filed 2012-11-08 | |
| 2012-06-30 | $142.00K 10-Q · filed 2012-08-10 | |
| 2012-03-31 | $711.00K 10-Q · filed 2012-05-15 | |
| 2011-12-31 | $756.00K 10-K · filed 2013-03-22 | |
| 2011-09-30 | $744.00K 10-Q · filed 2011-11-15 | |
| 2011-06-30 | $830.00K 10-Q/A · filed 2011-11-17 | $270.00K 10-Q · filed 2011-08-11 |
| 2010-12-31 | $2.16M 10-K · filed 2012-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |